It has also been reported that in non-small-cell lung cancer and prostate cancer cells, p53 expression induces apoptosis and enhances chemotherapeutic cytotoxic effects of docetaxel which is in agreement with our findings (31, 32). Here, TP53 is linked to prostate carcinoma.